Terms: = Lymphoma AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Treatment
20 results:
1. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
[TBL] [Abstract] [Full Text] [Related]
2. A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes.
Cheleschi S; Tenti S; Giannotti S; Veronese N; Reginster JY; Fioravanti A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445685
[TBL] [Abstract] [Full Text] [Related]
3. Vorinostat ameliorates IL-1α-induced reduction of type II collagen by inhibiting the expression of ELF3 in chondrocytes.
Miao X; Wu Y; Wang P; Zhang Q; Zhou C; Yu X; Cao L
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22844. PubMed ID: 34250664
[TBL] [Abstract] [Full Text] [Related]
4.
Yang HL; Liu HW; Shrestha S; Thiyagarajan V; Huang HC; Hseu YC
Aging (Albany NY); 2021 May; 13(12):15964-15989. PubMed ID: 34031264
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the Crosstalk between Hydrostatic Pressure and Adipokines: An In Vitro Study on Human Osteoarthritic Chondrocytes.
Cheleschi S; Tenti S; Barbarino M; Giannotti S; Bellisai F; Frati E; Fioravanti A
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803113
[TBL] [Abstract] [Full Text] [Related]
6. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract] [Full Text] [Related]
7. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract] [Full Text] [Related]
8. Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Munakata W; Ando K; Hatake K; Fukuhara N; Kinoshita T; Fukuhara S; Shirasugi Y; Yokoyama M; Ichikawa S; Ohmachi K; Gion N; Aoi A; Tobinai K
Cancer Sci; 2019 May; 110(5):1686-1694. PubMed ID: 30815927
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
[TBL] [Abstract] [Full Text] [Related]
10. Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009.
Mueller EL; Walkovich KJ; Mody R; Gebremariam A; Davis MM
BMC Cancer; 2015 May; 15():388. PubMed ID: 25957578
[TBL] [Abstract] [Full Text] [Related]
11. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
Ravillah D; Mohammed A; Qian L; Brewer M; Zhang Y; Biddick L; Steele VE; Rao CV
J Pharmacol Exp Ther; 2014 Jan; 348(1):59-68. PubMed ID: 24218540
[TBL] [Abstract] [Full Text] [Related]
12. SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies.
Hart S; Goh KC; Novotny-Diermayr V; Hu CY; Hentze H; Tan YC; Madan B; Amalini C; Loh YK; Ong LC; William AD; Lee A; Poulsen A; Jayaraman R; Ong KH; Ethirajulu K; Dymock BW; Wood JW
Leukemia; 2011 Nov; 25(11):1751-9. PubMed ID: 21691275
[TBL] [Abstract] [Full Text] [Related]
13. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma.
William AD; Lee AC; Blanchard S; Poulsen A; Teo EL; Nagaraj H; Tan E; Chen D; Williams M; Sun ET; Goh KC; Ong WC; Goh SK; Hart S; Jayaraman R; Pasha MK; Ethirajulu K; Wood JM; Dymock BW
J Med Chem; 2011 Jul; 54(13):4638-58. PubMed ID: 21604762
[TBL] [Abstract] [Full Text] [Related]
14. Avascular necrosis of the femoral head in patients with Hodgkin's disease.
Renedo RJ; Sousa MM; Pérez SF; Zabalbeascoa JR; Carro LP
Hip Int; 2010; 20(4):473-81. PubMed ID: 21157752
[TBL] [Abstract] [Full Text] [Related]
15. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
[TBL] [Abstract] [Full Text] [Related]
16. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
Wöhrer S; Troch M; Zwerina J; Schett G; Skrabs C; Gaiger A; Jaeger U; Zielinski CC; Raderer M
Ann Oncol; 2007 Apr; 18(4):647-51. PubMed ID: 17218490
[TBL] [Abstract] [Full Text] [Related]
17. Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
Alinari L; Ambrosini V; Castellucci P; Tani M; Stefoni V; Nanni C; Farsad M; Rubello D; Franchi R; Zinzani PL; Fanti S
Leuk Lymphoma; 2006 Jun; 47(6):1048-52. PubMed ID: 16840196
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin lymphoma Study Group.
Josting A; Rueffer U; Franklin J; Sieber M; Diehl V; Engert A
Blood; 2000 Aug; 96(4):1280-6. PubMed ID: 10942369
[TBL] [Abstract] [Full Text] [Related]
19. [Adult T-cell leukemia with massive melena due to marked gastrointestinal involvement].
Nakasone T; Masuda M; Arakaki H; Shimoji T; Araki K; Mimura G
Rinsho Ketsueki; 1989 Oct; 30(10):1848-52. PubMed ID: 2593252
[TBL] [Abstract] [Full Text] [Related]
20. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract] [Full Text] [Related]
